Which hedge funds own HRTX? HERON THERAPEUTICS INC, Q2 2026 13F holders
HealthcareBiotechnologyFollow
20 tracked hedge funds disclosed a position in HRTX (HERON THERAPEUTICS INC) in their Q2 2026 13F filings, worth $28.7m in total. The largest holder by portfolio weight is Tejara Capital Ltd at 1.1% of its book. 4 opened a new position this quarter: Diadema Partners LP, Persistent Asset Partners Ltd, Marshall Wace, LLP, Centiva Capital, LP. 3 exited: Orbimed Advisors LLC, NINE MASTS CAPITAL Ltd, Citadel Advisors LLC.
20
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
4
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
3
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$1.3m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$8.5m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$28.7m
Combined value
Sum of the holders' reported positions in the security.
1.6%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.